Global Clinical Trial Imaging Market is Determined to Cross US$ 981 Million By 202


No comments posted yet


Slide 1

Global Clinical Trial Imaging Market is Determined to Cross US$ 981 Million By 202 Market Research Engine has published a new report titled as “Clinical Trial Imaging Market By Product Segment Analysis (Software, Service, System and technology, Reader service, Operational imaging services, Design consulting); By Modality Analysis (X ray, PET, CT, MRI, Ultrasound, Echo); By End-user Analysis (Academic and government research institutes, Medical devices manufacturers, Biopharmaceutical companies, CROs) and By Regional Analysis – Global Forecast by 2016 - 2022” The Clinical Trial Imaging Market is Expected to Exceed more than US$ 981 Million by 2020. You Can Browse Full Report: imaging-market Clinical imaging is essential element of the expensive research and development method of biotechnology and pharmaceutical industries. The usage of medical imaging is established in clinical trials, for making trials more accurate and effective. Clinical trial imaging brings information of human physiology /anatomy, changeable from incontestable interpretable information to information which is of uncertain value. The image presenting long fractured bone is basically understood rather than a sharing of uncharacterized ligand receptor in cerebral cortex is meaningless. The clinical assumptions of an image are essential in evaluating the medicine effect. Clinical imaging is used on daily base to manage, prevent, treat, detect, and various diseases or medical conditions. The major driving factors of global clinical trial imaging market are as follows: Rise in R&D spending Rising number of cros Development in the biotechnology and pharmaceutical Industries The restraining factors of global clinical trial imaging market are as follows: High implementation charge of imaging systems The Global clinical trial imaging market is segmented on the lines of its products, modality, end users and regional. The products are further segmented into software and services. Based on services segmentation it covers into system and technology, reader service, operational imaging services and design consulting. The modality market is classified intoX ray, PET, CT, MRI, ultrasound, echo and others. The CT has the main share in the clinical trial imaging market. End users segmented into academic and government research institutes, medical devices manufacturers, biopharmaceutical companies, CROs and others. Theclinical trial imaging market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Slide 2

This report provides: An overview of the global market for global clinical trial imaging market and related technologies. Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020. Identifications of new market opportunities and targeted promotional plans for global clinical trial imaging market. Discussion of research and development, and the demand for new products and new applications. Comprehensive company profiles of major players in the industry. REPORT SCOPE: The scope of the report includes a detailed study of global and regional markets Global clinical trial imaging market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include BioClinica Inc, Cardiovascular Imaging Technologies, ICON plc, Biomedical Systems, Intrinsic Imaging LLC, PAREXEL International Corporation, VirtualScopic Inc and Prism Clinical Imaging. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. The Global Clinical trial imaging Market has been segmented as below: By Product Segment Analysis Software Service System and technology Reader service Operational imaging services Design consulting. By Modality Analysis X ray PET CT MRI Ultrasound Echo Others By End-user Analysis Academic and government research institutes Medical devices manufacturers

Slide 3

Biopharmaceutical companies CROs Others By Regional Analysis North America Europe Asia-Pacific Rest of the World Request Sample Report: market Table of Contents INTRODUCTION Research Methodology Executive Summary Premium Insights Market Overview Clinical Trial Imaging Market, By Product and Service 7 Clinical Trial Imaging Market, By Modality 8 Clinical Trial Imaging Market, By End User 9 Clinical Trial Imaging Market, By Region 10 Competitive Landscape Company Profiles Introduction Bioclinica, Inc. Parexel International Corporation Icon PLC Biomedical Systems Corporation Biotelemetry, Inc.

Slide 4

Cardiovascular Imaging Technologies, LLC Intrinsic Imaging LLC Ixico PLC Radiant Sage LLC Worldcare Clinical, LLC Media Contact Company Name: Market Research Engine Contact Person: John Bay Email: Phone: +1-855-984-1862 Country: United States Website:

Summary: The Clinical Trial Imaging Market is Expected to Exceed more than US$ 981 Million by 2020.

Tags: global clinical trial imaging market